Simulation-driven optimization of insulin therapy profiles in a commercial hybrid closed-loop system
- 2 October 2023
- journal article
- research article
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 242, 107830
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 DiabetesNew England Journal of Medicine, 2019
- One Year Clinical Experience of the First Commercial Hybrid Closed-Loop SystemDiabetes Care, 2019
- Closed-loop control with unannounced exercise for adults with type 1 diabetes using the Ensemble Model Predictive ControlJournal of Process Control, 2019
- The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single DayJournal of Diabetes Science and Technology, 2018
- Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and HypoglycemiaDiabetes Care, 2017
- Bolus Advisors: Sources of Error, Targets for ImprovementJournal of Diabetes Science and Technology, 2017
- Metrics for glycaemic control — from HbA1c to continuous glucose monitoringNature Reviews Endocrinology, 2017
- Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico ResultsIEEE Transactions on Biomedical Engineering, 2017
- AMIGO, a toolbox for advanced model identification in systems biology using global optimizationBioinformatics, 2011
- An iterative identification procedure for dynamic modeling of biochemical networksBMC Systems Biology, 2010